Physician profile
Alison J Garten
NPI 1033135207
$418,515.46
in general payments reported to CMS, 2019-2025
26 companies · $28K in 2025
The $28K reported for 2025 was more than what 98% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37K · 2020: $46K · 2021: $140K · 2022: $72K · 2023: $57K · 2024: $38K · 2025: $28K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $62K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $51K · Travel and Lodging: $7,089 · Food and Beverage: $3,070 · Education: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $61,891.97 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $50,584.38 |
| Travel and Lodging | $7,088.66 |
| Food and Beverage | $3,069.96 |
| Education | $350.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hartmann USA, INC. | $279,174.55 | 2020-2024 | Zetuvit, Zetuvit Plus 10x10 P10, Zetuvit Plus |
| Smith+Nephew, INC. | $126,095.06 | 2019-2025 | Grafix, Na, Grafix Pl |
| Abbvie INC. | $12,076.02 | 2023-2025 | |
| Treace Medical Concepts, INC. | $193.08 | 2022 | |
| Boston Scientific Corporation | $150.00 | 2025 | General - Angiography |
| Next Science LLC | $109.07 | 2023-2024 | Blastx, Surgx, Xperience |
| Organogenesis INC. | $101.49 | 2021-2023 | Puraply |
| Tactile Systems Technology INC | $89.45 | 2022-2024 | Entre Plus, Flexitouch Plus |
| Triad Life Sciences INC. | $80.70 | 2022 | |
| Polynovo North America LLC | $56.69 | 2024 | Novosorb Btm |
| Paratek Pharmaceuticals, INC. | $54.22 | 2023-2025 | Nuzyra |
| Advanced Oxygen Therapy INC. | $50.24 | 2024-2025 | Topical Oxygen Chamber For Extremities |
| Stryker Corporation | $45.86 | 2022-2024 | 1788 |
| Kerecis Limited | $30.20 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Averitas Pharma INC. | $25.21 | 2024 | Qutenza |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $22.55 | 2024 | |
| Medline Industries LP | $20.33 | 2024 | |
| Grt US Holding, INC. | $19.39 | 2022 | |
| Peerless Surgical INC. | $18.57 | 2024 | |
| Molnlycke Health Care US, LLC | $16.70 | 2022 | |
| Integra Lifesciences Corporation | $16.47 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Solventum Corporation | $16.25 | 2024 | Activ.A.C. |
| Reapplix INC. | $13.80 | 2025 | 3c Patch Kit - Box |
| Musculoskeletal Transplant Foundation INC. | $13.42 | 2023 | |
| Urgo Medical North America, LLC | $13.21 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Hydrofera LLC | $12.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alison Garten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.